These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The measured effect of phenytoin withdrawal on gingival hyperplasia in children. Brunsvold M; Tomasovic J; Ruemping D ASDC J Dent Child; 1985; 52(6):417-21. PubMed ID: 3864798 [TBL] [Abstract][Full Text] [Related]
3. Diphenylhydantoin-induced gingival hyperplasia: its relationship to dose and serum level. Kapur RN; Girgis S; Little TM; Masotti RE Dev Med Child Neurol; 1973 Aug; 15(4):483-7. PubMed ID: 4732898 [No Abstract] [Full Text] [Related]
4. Effective treatment of Dilantin gingival hyperplasia. Sheridan PJ; Reeve CM Oral Surg Oral Med Oral Pathol; 1973 Jan; 35(1):42-6. PubMed ID: 4565186 [No Abstract] [Full Text] [Related]
5. [Clinical study of gingival hyperplasia in epilepsy patient]. Takagi M; Kojima T; Shimooka S; Katagiri M Shigaku; 1989 Dec; 77(4):1401-7. PubMed ID: 2535149 [TBL] [Abstract][Full Text] [Related]
6. Periodontic/orthodontic management of diphenylhydantoin gingival hyperplasia: case report. Vandersall DC; Slade D J Periodontol; 1976 Nov; 47(11):656-60. PubMed ID: 1068273 [TBL] [Abstract][Full Text] [Related]
7. [Case of gingival hyperplasia due to diphenylhydantoin]. Bella G; Rossetti B; Greco S; Indelicato F Minerva Stomatol; 1987 May; 36(5):367-71. PubMed ID: 3476825 [No Abstract] [Full Text] [Related]
8. Effect of 5,5-diphenylhydantoin on a gingival hyperplasia development. Drízhal I; Spacek J; Hrdinová V; Lichý J; Kaut V Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):625-89. PubMed ID: 6972082 [No Abstract] [Full Text] [Related]
9. [Epilepsy, medical therapy and relation to dentistry. Report of 3 clinical cases of hydantoin gingival hypertrophy]. Levratti E; Simoncello P Minerva Ortognatod; 1990; 8(2):103-9. PubMed ID: 2278749 [TBL] [Abstract][Full Text] [Related]
10. [Gingival hyperplasia in epileptic patients treated with diphenylhydantoin. Study by light and electron microscopy]. Tsutsumi V; Hara Ortíz F; Alvarez Fuertes G Rev Invest Salud Publica; 1973; 33(3-4):1-16. PubMed ID: 4791088 [No Abstract] [Full Text] [Related]
11. [Histopathology of gingival manifestations of hydantoin therapy]. Hanzély B Fogorv Sz; 1976; 69 Suppl():418-20. PubMed ID: 1071997 [No Abstract] [Full Text] [Related]
12. [Histopathological study on diphenylhydantoin gingival hyperplasia in rats, especially the role of gingival inflammation in diphenylhydantoin gingival hyperplasia]. Watanabe H Nihon Shishubyo Gakkai Kaishi; 1982 Sep; 24(3):385-408. PubMed ID: 6962259 [No Abstract] [Full Text] [Related]
14. Diphenylhydantoin-induced gingival hyperplasia: its response to changes in drug dosage. Little TM; Girgis SS; Masotti RE Dev Med Child Neurol; 1975 Aug; 17(4):421-4. PubMed ID: 1158048 [TBL] [Abstract][Full Text] [Related]
15. [On the clinical features, histology and etiology of gingival hyperplasia and the hydantoins]. Gottwald W Zahnarztl Welt Zahnarztl Rundsch ZWR Zahnarztl Reform; 1969 Jan; 78(1):24-9. PubMed ID: 4891586 [No Abstract] [Full Text] [Related]
16. The effect of oral physiotherapy on dilantin gingival hyperplasia. King DA; Hawes RR; Bibby BG J Oral Pathol; 1976 Jan; 5(1):1-7. PubMed ID: 814217 [TBL] [Abstract][Full Text] [Related]
17. Diphenylhydantoin gingival hyperplasia in Macaca arctoides: a new human model. Staple PH; Reed MJ; Mashimo PA J Periodontol; 1977 Jun; 48(6):325-36. PubMed ID: 405470 [No Abstract] [Full Text] [Related]
18. Diphenylhydantoin-induced gingival overgrowth in man: a clinico-pathological study. Peñarrocha-Diago M; Bagán-Sebastián JV; Vera-Sempere F J Periodontol; 1990 Sep; 61(9):571-4. PubMed ID: 2213467 [TBL] [Abstract][Full Text] [Related]